NDC codes

FDA NDC Directory
Product NDC (as listed)71705-050Labeler and product segments. Claims need a package NDC.
Product NDC at billing width71705-0050Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
71705-050-0171705005001500 TABLET in 1 BOTTLE, PLASTIC (71705-050-01)Marketed from Dec 2, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Moxidectin
Generic name (nonproprietary)
moxidectin
Active ingredients
Moxidectin — 2 mg/1
Dosage form
Tablet
Route
Oral
Labeler
Medicines Development for Global HealthNDC labeler code 71705
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 210867
Marketing start
Listing expires
Identifiers
Product ID 71705-050_57da9591-29d9-73ff-e063-6294a90aec6aSPL ID 57da9591-29d9-73ff-e063-6294a90aec6aSPL set ID 6eb02ae9-9065-176f-e053-2991aa0ac891RxCUI 2049015UNII NGU5H31YO9UPC 0371705050011

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471705005001 followed by a unit qualifier and the quantity

Package 71705-0050-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Moxidectin Tablets are indicated for the treatment of onchocerciasis due to Onchocerca volvulus in adult and pediatric patients aged 4 years and older and weighing at least 13 kg [see Clinical Studies ( 14 )] . Limitations of Use: Moxidectin Tablets does not kill adult Onchocerca volvulus (O. volvulus) parasites . Follow-up evaluation is advised. The safety and efficacy of repeat administration of Moxidectin Tablets in patients with O . volvulus has not been studied. Moxidectin is an anthelmintic indicated for the treatment of onchocerciasis due to Onchocerca volvulus in adults and pediatric patients aged 4 years and older and weighing at least 13 kg. ( 1 ) Limitations of Use: Moxidectin Tab…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71705-050

What is NDC 71705-050?
71705-050 is the product NDC for Moxidectin, Moxidectin 2 mg/1 tablet, listed with the FDA by Medicines Development for Global Health. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Moxidectin.
What is the active ingredient?
Moxidectin.
Who is the labeler?
Medicines Development for Global Health, NDC labeler code 71705. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Moxidectin?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in